4.7 Review

Fall risk-increasing drugs and gait performance in community-dwelling older adults: A systematic review

期刊

AGEING RESEARCH REVIEWS
卷 77, 期 -, 页码 -

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.arr.2022.101599

关键词

Psychotropic drugs; Cardiovascular drugs; Medication; Gait; Aging; Systematic review

资金

  1. Canadian Institutes of Health Research (CIHR) [MOP 211220, PJT 153100]
  2. Ontario Ministry of Research and Innovation [ER11-08-101]
  3. Ontario Neurodegenerative Diseases Research Initiative [OBI 34739]
  4. Department of Medicine Program of Experimental Medicine Research Award, the University of Western Ontario [POEM 768915]
  5. Schulich Clinician-Scientist Award
  6. CCNA Canadian Consortium on Neurodegeneration in Aging (CCNA) [FRN CNA 137794]

向作者/读者索取更多资源

The purpose of this review was to systematically evaluate the association between FRIDs and gait performance in community-dwelling older adults without neurological movement disorders. The study found that drugs with sedative properties are associated with reduced gait speed in older adults, while statin use has no association with gait speed. There is insufficient evidence on the association between FRIDs and other gait performance measures.
Purpose: Medication use, and gait impairment are two major risk factors for falls in older adults. There are several mechanisms linking fall risk-increasing drugs (FRIDs) and increased fall risk. One pathway involves gait per-formance as an intermediate variable. It is plausible that FRIDs indirectly increase fall risk by causing gait impairment. The purpose of this review was to systematically review the existing evidence on the association between FRIDs and gait performance in community-dwelling older adults without neurological movement disorders. Methods: Two searches were performed using MeSH terms and keywords in the electronic databases MEDLINE, EMBASE, PsycINFO, CINAHL and grey literature. We included clinical trials and observational studies that assessed the association between a FRID class and any quantitative measure of gait performance. Quality assessment was performed using the Newcastle-Ottawa scale for observational studies and the Cochrane risk-of -bias tool for clinical trials. Study characteristics and findings were summarized in a descriptive approach for each drug class. Results: A total of 11,197 studies were retrieved from both searches at the first step and a total of 23 studies met the final inclusion criteria. Fourteen studies assessed the association between psychotropic FRIDs and gait per-formance and nine assessed cardiovascular FRIDs. Four out of five studies found that drugs with sedative properties are associated with reduced gait speed in older adults. Three out of four studies found no association between statin use and gait speed. There is insufficient evidence on the association between FRIDs and other gait performance measures. Conclusion: Caution should be taken when prescribing drugs with sedative properties to older adults at risk of falls. Further research is required to assess the impact of the use FRIDs on gait performance measures other than gait speed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据